Cognitive Disengagement Syndrome: Not Quite ADHD, Not Quite Anything Else

There's a little-known ADHD-like syndrome that sometimes comes to mind when I'm performing an ADHD assessment. It's usually triggered when I talk to someone with noted slow processing speed that shows as slow actions or as slow processing of verbal or written material, who spends a lot of time in their head, often day-dreaming, and who often feels spacey or disconnected from what's occurring around them. While these clients generally fit within an inattentive ADHD presentation, there's something a bit different about the way their brains engage with the world than most of my ADHD clients. And there is some literature on, and even a name for this pattern: Cognitive Disengagement Syndrome (CDS).

If you've come across this concept before, you may know it by its older name: Sluggish Cognitive Tempo (SCT). An international panel of researchers retired that name in 2022, on the reasonable grounds that "sluggish" sounds like a character flaw rather than a cognitive profile (who wants to identify with being sluggish?).

A Bit of History

CDS isn't new. The symptom cluster was first described in the mid-1980s, originally as a possible subtype of inattentive ADHD. Decades of research have since shifted the conclusion: CDS is related to ADHD, but separable from it. It isn't currently in the DSM-5 diagnostic manual. It does appear as a diagnostic descriptor in another diagnostic system: the ICD-11, and an international working group has concluded that the evidence base is now strong enough to consider it a distinct syndrome.

The core symptoms cluster around three themes:

• Excessive daydreaming and mind-wandering — the internal world is more compelling than the external one

• Mental fog or confusion — that "blank screen" feeling, losing the thread, struggling to orient

• Slowed thinking, slowed movement, low arousal — physical and cognitive hypoactivity

In practice, this looks like someone who stares, zones out, takes a long time to start or finish tasks, seems sleepy or lethargic, and often describes themselves as feeling "in a fog" or "not quite here" (not everyone is going to have all of these characteristics).

How is it Different From Inattentive ADHD?

There is an overlap. Both involve attention difficulties. Both can produce the picture of a quiet, dreamy person who never finished their schoolwork on time. A few useful distinctions:

A big part of ADHD inattention is about distractibility and a difficulty sustaining attention once it's engaged. The person may be able to start, but pulls away by the environment, by another thought, by the next thing.

CDS is more about disengagement from the outset, a difficulty getting attention online and powered up in the first place. The internal world is the distraction moreso than the environment.

There are other differences worth knowing. CDS tends to onset slightly later than ADHD. It appears to be less heritable, suggesting environmental and developmental factors play a relatively larger role. CDS is more strongly linked to depression and social withdrawal; ADHD is more strongly linked to anxiety and (obviously) hyperactivity-impulsivity. Executive function deficits do exist in CDS, but tend to be milder, and the executive functioning problems that do show up are often better explained by co-occurring ADHD symptoms.

The two genuinely do co-occur. Estimates suggest that somewhere between a quarter and a half of people with ADHD also have elevated CDS symptoms, particularly those with the inattentive presentation. When both are present, impairment is worse than when either is present alone.

What About Treatment?

We don't have a clear evidence-based protocol for CDS yet. A few signals from the research so far:

Stimulants - the first-line treatment for ADHD - appear to help CDS symptoms less reliably, and elevated CDS symptoms may predict a poorer overall stimulant response. The findings here are mixed: some studies show methylphenidate improving daydreaming-type symptoms, others show no relationship at all, and at least one randomised trial found that higher CDS symptoms predicted poorer methylphenidate response (Froehlich et al., 2018; Fırat et al., 2021). That said, the most relevant adult evidence is more encouraging: a small crossover trial found that lisdexamfetamine reduced CDS symptoms in adults with co-occurring ADHD, and only about a quarter of that improvement was explained by the improvement in ADHD symptoms, suggesting it was acting on CDS in its own right (Adler et al., 2021). What's reasonably consistent across the literature is that people with ADHD plus CDS may respond to stimulants for their ADHD features, even where the CDS symptoms are more stubborn.

Atomoxetine, a non-stimulant noradrenergic medication also used for ADHD, has shown some promise for reducing CDS symptoms specifically and, the improvement appeared to be partially independent of any change in ADHD inattention rather than just a knock-on effect (Wietecha et al., 2013; McBurnett et al., 2017). Two caveats worth holding in mind: this evidence comes from a single trial in children and adolescents (not adults), and the study was funded by Eli Lilly, atomoxetine's manufacturer.

Psychological approaches are where the evidence is thinnest. The strongest evidence relates to sleep and circadian rhythm. Recent adult research found that CDS symptoms are uniquely associated with poorer sleep quality, longer time to fall asleep, more daytime dysfunction, and a preference for "eveningness", independent of ADHD symptoms (Knouse & Becker, 2025).

Mindfulness and CBT are widely recommended for CDS, but mostly on the basis of clinical reasoning rather than dedicated trials, the idea being that mindfulness builds awareness of internal disengagement and CBT can target activation, organisation, and procrastination.

Clinically, the most useful starting point is often just naming the pattern. People with CDS-type symptoms have usually spent years being told they're lazy, slow, or not trying hard enough. Recognising it as a cognitive tempo difference rather than a motivational failure may reduce shame and open up self-advocacy. This could also include thinking about the types of jobs that might best be avoided - like high-energy or fast-paced environments.

Where This Leaves Us

CDS isn't a tidy diagnostic category yet. It may end up being a distinct disorder, a specifier within ADHD, or a transdiagnostic dimension that cuts across several conditions.

What we can say is that the pattern is real, it isn't synonymous with inattentive ADHD, and it has a different functional fingerprint. For now, in assessment, I think the useful work is to notice when it might be present. If someone is describing internal disengagement rather than external distractibility, mental fog rather than racing thoughts, slowed processing rather than dysregulated arousal, then that's something to remember and perhaps provide some information about, even if we don't have firm evidence for what would be optimally helpful at this stage.

Further Reading

• ADDitude Magazine — Cognitive Disengagement Syndrome: Overview, Symptoms, ADHD Connection. An accessible overview written by Joseph Fredrick and Stephen Becker, two of the leading CDS researchers.

• CHADD — Cognitive Disengagement Syndrome. A clear summary aimed at clinicians and families.

• Becker, S. P. (2025) — Cognitive disengagement syndrome: A construct at the crossroads. A recent academic review setting out the state of the field and the key open questions.

• Barkley, R. A. (2023). The Other Attention Disorder: Cognitive Disengagement Syndrome (formerly Sluggish Cognitive Tempo) versus ADHD. https://www.youtube.com/playlist?list=PLKF2Eq0eYbbpX9cuAuG7BIWjB5sGNexGX. This is a six-part video exploration by Professor Russell Barkley, with each part 20-30 minutes long.